Physicochemical and biologic comparability of a biosimilar granulocyte colony-stimulating factor with its reference product.
about
Spin Diffusion Editing for Structural Fingerprints of Therapeutic AntibodiesUpdate on the safety and bioequivalence of biosimilars - focus on enoxaparin.Use of biosimilar filgrastim compared with lenograstim in autologous haematopoietic stem-cell transplant and in sibling allogeneic transplant.Comparability of biosimilar filgrastim with originator filgrastim: protein characterization, pharmacodynamics, and pharmacokinetics.Safety and efficacy of granulocyte colony-stimulating factor biosimilars in engraftment after autologous stem cell transplantation for haematological malignancies: a 4-year, single institute experience with different conditioning regimensA non-interventional study of biosimilar granulocyte colony-stimulating factor as prophylaxis for chemotherapy-induced neutropenia in a community oncology centre.Characterization and comparison of commercially available TNF receptor 2-Fc fusion protein productsZarzio®, biosimilar of filgrastim, in prophylaxis of chemotherapy-induced neutropenia in routine practice: a French prospective multicentric studyAnalytical tools for characterizing biopharmaceuticals and the implications for biosimilars.Clinical experience with Zarzio® in Europe: what have we learned?Evaluation of a biosimilar granulocyte colony-stimulating factor (filgrastim XM02) for peripheral blood stem cell mobilization and transplantation: a single center experience in Japan.Healthy donor hematopoietic stem cell mobilization with biosimilar granulocyte-colony-stimulating factor: safety, efficacy, and graft performance.Top-down MS for rapid methionine oxidation site assignment in filgrastim.Biosimilars of filgrastim in autologous stem cell transplant: reduction in granulocyte-colony stimulating factor costs, but similar effects on bone marrow recovery.Plerixafor and Filgrastim XM02 (Tevagastrim) as a first line peripheral blood stem cell mobilisation strategy in patients with multiple myeloma and lymphoma candidated to autologous bone marrow transplantation.Biosimilar rhG-CSFs: how similar are they?2D (1)H(N), (15)N Correlated NMR Methods at Natural Abundance for Obtaining Structural Maps and Statistical Comparability of Monoclonal Antibodies.Improving Access to Cancer Treatments: The Role of Biosimilars.Development of an LC-MS/MS peptide mapping protocol for the NISTmAb.Scientific considerations for assessing biosimilar products.Peripheral blood stem cell mobilization and engraftment after autologous stem cell transplantation with biosimilar rhG-CSF.Quality Comparison of Biosimilar and Copy Filgrastim Products with the Innovator ProductFirst experience of autologous peripheral blood stem cell mobilization with biosimilar granulocyte colony- stimulating factor
P2860
Q28822541-BE626D6C-671E-437F-BDB3-AC20B0ABF1DCQ34352446-D513C1B4-FBB7-4953-8526-7D612375A778Q35192785-B58F4D9F-F025-4517-AFB9-E48B45BA7932Q35547653-59A8E425-4478-452F-93E1-8C95BDDC5005Q36187379-E10B7CFF-8199-42B3-80B3-9F480F7A0204Q36348464-2E4E7454-2829-43A3-A380-0798E8CE9D70Q36411858-4C304CFF-BA25-4292-96AF-72BFD60A353DQ36723952-17CF6143-81C5-4C57-AB39-A49007D72333Q37022207-CC776FEC-9A6C-4DB2-8E10-CA4B47317715Q38125609-66B675A3-556C-4D44-B539-C274DEDC3788Q38969947-42AF4FDB-427E-4B2A-958C-D16805B6655AQ39385304-DFB06309-A88B-4561-9DCE-2FBA6DC07DF4Q41976373-20E97A56-B7BD-4A2D-B32F-276A3787AAECQ42267665-7633988D-C43D-4081-A869-CF263A96EE0DQ44894394-4BE2C579-4134-4330-9075-003C95B6D88CQ45788056-8DAEAEE1-90FD-485A-AA8A-39A6AF220105Q46656897-EC63E89B-61F1-4C5B-B821-18E51147E3FAQ47099597-C05CB574-76A5-4201-8067-26EB28C3DFD6Q50057241-53EB4CD6-0463-443F-8CFC-94D0E0431A52Q50429210-F0ACABA3-9418-4617-B9A3-340CB90C3A4DQ51149892-F4761837-8F0C-4D28-ADC3-65135D135746Q57049370-277F23DC-CD2E-4844-8C41-7EE18BBF5A32Q57217646-C9F2F0B0-D930-4546-8D55-76DDBC40D97E
P2860
Physicochemical and biologic comparability of a biosimilar granulocyte colony-stimulating factor with its reference product.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Physicochemical and biologic c ...... or with its reference product.
@ast
Physicochemical and biologic c ...... or with its reference product.
@en
type
label
Physicochemical and biologic c ...... or with its reference product.
@ast
Physicochemical and biologic c ...... or with its reference product.
@en
prefLabel
Physicochemical and biologic c ...... or with its reference product.
@ast
Physicochemical and biologic c ...... or with its reference product.
@en
P2093
P1433
P1476
Physicochemical and biologic c ...... or with its reference product.
@en
P2093
Fritz Sörgel
Helmut Lerch
Thomas Lauber
P304
P356
10.2165/11585100-000000000-00000
P577
2010-12-01T00:00:00Z
P6179
1046065033